1. Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA). (3rd September 2017) Authors: Møller-Bisgaard, S; Ejbjerg, BJ; Eshed, I; Hørslev-Petersen, K; Hetland, ML; Jurik, AG; Thomsen, H; Torfing, T; Stengaard-Pedersen, K; Junker, P; Krogh, NS; Lottenburger, T; Ellingsen, T; Andersen, LS; Skjødt, H; Svendsen, AJ; Tarp, U; Hansen, IT; Pødenphant, J; Pedersen, JK Journal: Scandinavian journal of rheumatology Issue: Volume 46:Number 5(2017) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial. (4th July 2022) Authors: Møller-Bisgaard, S; Hørslev-Petersen, K; Ejbjerg, B; Hetland, ML; Christensen, R; Ørnbjerg, LM; Glinatsi, D; Møller, JM; Boesen, M; Stengaard-Pedersen, K; Madsen, OR; Jensen, B; Villadsen, JA; Hauge, EM; Bennett, P; Hendricks, O; Asmussen, K; Kowalski, M; Lindegaard, H; Bliddal, H Journal: Scandinavian journal of rheumatology Issue: Volume 51:Number 4(2022) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗